Transcatheter Chemoembolization in the Treatment of HCC in Patients not Eligible for Curative Treatments: Mid-term Results of Doxorubicin-loaded DC Bead Malagari K, Alexopoulou E, …
Early Experience of Trans-arterial Chemo-Embolisation for ...
Aug 27, 2019 · To evaluate early outcomes of patients with hepatocellular carcinoma (HCC) treated with a novel radiopaque bead, the 75–150 μm DC Bead LUMI™ (Biocompatibles UK Ltd).This was a …
Safety, Efficacy and Distribution of Doxorubicin Loaded ...
Jan 18, 2023 · Purpose The primary objectives of this study were to evaluate safety, and efficacy of Transarterial Chemoembolization (TACE) using doxorubicin-loaded radiopaque microspheres (DC …
DC-Beads M1™ loaded with Irinotecan combined with systemic ...
The use of trans-arterial chemo-embolization with irinotecan drug eluted beads (DEBIRI) for liver-dominant metastatic colorectal cancer (mCRC) is usually proposed for end-stage patients as a …
Transarterial Treatment of Colorectal Cancer Liver Metastases ...
Jun 24, 2013 · Transcatheter hepatic arterial administration of irinotecan-loaded drug-eluting beads (DEBIRI) is used to treat liver-only or liver-dominant metastatic disease from colorectal cancer …
Transcatheter embolization therapy in liver cancer: an update ...
Drug-eluting bead (DEB) is a relatively novel drug delivery embolization system which allows for fixed dosing and the ability to release the anticancer agents in a sustained manner. Three DEBs are …
Drug-Eluting Beads - Radiology Key
Dec 3, 2016 · Matthew E. Anderson • Sanjeeva P. Kalva The introduction of drug-eluting beads represents a shift in the principal way in which chemotherapeutic agents are delivered, concentrated, …